Flutamide
Congenital Adrenal Hyperplasia
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Small moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
12 Active assets in the Congenital Adrenal Hyperplasia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Hydrocortisone University of Texas Southwestern Medical Center | Phase 4 | A |
Cortisone Federico II University | Phase 4 | BBB |
Atumelnant Crinetics Pharmaceuticals Inc. | Phase 3 | BB |
Fludrocortisone University of Texas Southwestern Medical Center | Phase 3 | BB |
Dexasone Shanghai Jiao Tong University School of Medicine | Phase 4 | BB |
View all 18 →
Same molecule, other indications
Flutamide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →